Compounds > glutathione disulfide
Page last updated: 2024-08-24

glutathione disulfide and Carcinoma, Non-Small Cell Lung

glutathione disulfide has been researched along with Carcinoma, Non-Small Cell Lung in 4 studies

Research

Studies (4)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (50.00)29.6817
2010's1 (25.00)24.3611
2020's1 (25.00)2.80

Authors

AuthorsStudies
Akrami, M; Chamoto, K; Fagarasan, S; Hatae, R; Hirai, T; Honjo, T; Kawaguchi, S; Kim, YH; Masuda, I; Matsuda, F; Okuno, Y; Ozasa, H; Sakamori, Y; Sonomura, K; Taneishi, K; Yoshida, H1
Broggini, M; Brunelli, L; Caiola, E; Marabese, M; Pastorelli, R1
Tew, KD; Townsend, DM1
Garrett, TE; He, L; Hutchens, S; Pazoles, CJ; Tew, KD; Townsend, DM1

Other Studies

4 other study(ies) available for glutathione disulfide and Carcinoma, Non-Small Cell Lung

ArticleYear
Combination of host immune metabolic biomarkers for the PD-1 blockade cancer immunotherapy.
    JCI insight, 2020, 01-30, Volume: 5, Issue:2

    Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Agents, Immunological; Biomarkers, Tumor; Carcinoma, Non-Small-Cell Lung; Carnitine; Drug Therapy, Combination; Energy Metabolism; Female; Glutathione Disulfide; Hippurates; Humans; Immunotherapy; Lung Neoplasms; Male; Microbiota; Middle Aged; Nivolumab; Programmed Cell Death 1 Receptor; Prospective Studies

2020
Capturing the metabolomic diversity of KRAS mutants in non-small-cell lung cancer cells.
    Oncotarget, 2014, Jul-15, Volume: 5, Issue:13

    Topics: Blotting, Western; Carcinoma, Non-Small-Cell Lung; Cell Line, Tumor; Chromatography, Liquid; Codon; Gene Expression Regulation, Neoplastic; Glutathione; Glutathione Disulfide; Humans; Lung Neoplasms; Mass Spectrometry; Metabolic Networks and Pathways; Metabolomics; Mutation, Missense; Oligopeptides; ras Proteins; Reverse Transcriptase Polymerase Chain Reaction

2014
Pharmacology of a mimetic of glutathione disulfide, NOV-002.
    Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie, 2009, Volume: 63, Issue:2

    Topics: Animals; Antineoplastic Agents; Carcinoma, Non-Small-Cell Lung; Cisplatin; Clinical Trials as Topic; Drug Combinations; Glutathione Disulfide; Humans; Lung Neoplasms; Oxidation-Reduction; Signal Transduction; Survival Rate

2009
NOV-002, a glutathione disulfide mimetic, as a modulator of cellular redox balance.
    Cancer research, 2008, Apr-15, Volume: 68, Issue:8

    Topics: Antineoplastic Agents; Carcinoma, Non-Small-Cell Lung; Cell Line, Tumor; Cell Physiological Phenomena; Cell Survival; Cisplatin; Drug Combinations; Glutathione; Glutathione Disulfide; Humans; Lung Neoplasms; Oxidation-Reduction

2008